| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70ad9843b511c8e1109f09fef33dac2b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 |
| filingDate |
2019-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4257e6bf2bc34d68c1a59495b35322b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f4e8472cf4f75f85dd73bafdea11fd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50b4462967b2655ee23cc48be0b915ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_860e7a3502657585dca918c50124d54b |
| publicationDate |
2020-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200059178-A |
| titleOfInvention |
Pharmaceutical composition for preventing or treating cancer comprising streptonigrin and anticancer agent |
| abstract |
The present invention is streptoni green; And any one or more additional anti-cancer agents selected from the group consisting of cisplatin, gemcitabine and paclitaxel; It is for a pharmaceutical composition or an anti-cancer adjuvant for the prevention or treatment of cancer comprising all. Therefore, the composition comprising all of the streptonigreen and other anticancer agents of the present invention is effective as a composition for preventing or treating cancer because it has an excellent effect of inhibiting the growth of cancer cells, especially the effect of inhibiting the growth of ovarian cancer cells. . |
| priorityDate |
2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |